Invivyd holder plans sale of 40,800 shares

Invivyd, Inc. (symbol IVVD) filed a notice of proposed sale of 40,800 shares of common stock under Form 144.

Rhea-AI Filing Summary

Invivyd, Inc. (symbol IVVD) filed a notice of proposed sale of 40,800 shares of common stock under Form 144. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with sales expected to occur on or after August 17, 2026 on Nasdaq.

The seller’s shares were acquired as equity compensation: on August 15, 2026, 102,000 shares of common stock were acquired upon vesting of restricted stock units granted under the company’s 2021 Equity Incentive Plan. This filing serves as advance notice of the contemplated resale by an affiliate or holder subject to Rule 144.

Key Figures

Shares of common stock proposed to be sold: 40,800 shares Shares acquired upon RSU vesting: 102,000 shares Proposed sale start date: 08/17/2026 +1 more

4 metrics

Shares of common stock proposed to be sold 40,800 shares Maximum amount of common stock indicated for sale under Form 144

Shares acquired upon RSU vesting 102,000 shares Common stock acquired on 08/15/2026 upon vesting of restricted stock units

Proposed sale start date 08/17/2026 Approximate date sales of common stock may begin under the notice

RSU vesting date 08/15/2026 Date restricted stock units vested and were converted into common stock

Key Terms

Form 144, restricted stock units, 2021 Equity Incentive Plan, Equity Compensation

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock units financial

"Common Stock acquired upon vesting of restricted stock units granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2021 Equity Incentive Plan financial

"units granted under the Issuer's 2021 Equity Incentive Plan"

Equity Compensation financial

"102000 | 08/15/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Invivyd (IVVD) disclose in this Form 144 filing?

Invivyd (IVVD) discloses a proposed sale of 40,800 shares of common stock by an affiliated holder under Form 144. The filing provides advance notice of potential open-market sales subject to Rule 144 conditions.

How many Invivyd (IVVD) shares are proposed to be sold and when?

The filing reports a proposed sale of 40,800 shares of Invivyd common stock, with sales expected on or after August 17, 2026. Transactions are indicated as occurring on the Nasdaq market through the named broker.

How were the Invivyd (IVVD) shares in this Form 144 acquired?

The shares were acquired as equity compensation. On August 15, 2026, 102,000 shares of common stock were received upon vesting of restricted stock units under Invivyd’s 2021 Equity Incentive Plan.

Which broker is handling the proposed Invivyd (IVVD) Form 144 share sale?

The proposed sale of Invivyd (IVVD) shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The brokerage office is listed at 1 New York Plaza, 8th Floor, New York, NY 10004.

What type of security is covered in Invivyd’s (IVVD) Form 144?

The filing covers common stock of Invivyd (IVVD). These shares originated from vested restricted stock units granted under the company’s 2021 Equity Incentive Plan and are now subject to a proposed resale under Rule 144.

Is the Invivyd (IVVD) Form 144 filing itself a sale of shares?

No. Form 144 is a notice of proposed sale, not the sale itself. It discloses the intent to sell up to 40,800 shares, with actual transactions occurring separately on the market if executed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 04:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002008797
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Invivyd, Inc.
SEC File Number	001-40703
Address of Issuer	205 Church Street New Haven CONNECTICUT 06510
Phone	781-819-0080
Name of Person for Whose Account the Securities are To Be Sold	Green Julie
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40800	29412.72	294758746	08/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/15/2026	Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan	Issuer			102000	08/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This Form 144 reports shares to be sold to satisfy the Reporting Person's tax obligations upon vesting of a restricted stock unit award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan applicable to the Reporting Person. Aggregate Market Value of the sale is based on a closing price of $0.7209 for the Issuer's common stock on August 14, 2026. The actual number of shares sold will depend on the sale price of the Issuer's common stock at the time of sale.
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jill Andersen attorney-in-fact for Julie Green
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)